The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment
Clinical trial NCT01796288 · UNKNOWN
Trial details
- NCT number
- NCT01796288
- Sponsor
- Wu Jieping Medical Foundation
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-04-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.